| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 202.15B | 211.08B | 201.22B | 188.25B | 214.19B | 199.10B |
| Gross Profit | 30.03B | 32.20B | 29.86B | 28.62B | 29.07B | 26.39B |
| EBITDA | 14.81B | 16.44B | 14.88B | 12.91B | 13.15B | 11.74B |
| Net Income | 18.76B | 12.78B | 18.62B | 16.10B | 6.21B | 6.48B |
Balance Sheet | ||||||
| Total Assets | 248.39B | 272.38B | 257.11B | 259.88B | 232.75B | 229.73B |
| Cash, Cash Equivalents and Short-Term Investments | 15.87B | 21.05B | 24.85B | 18.51B | 13.61B | 14.47B |
| Total Debt | 54.52B | 58.82B | 57.20B | 59.30B | 63.42B | 66.16B |
| Total Liabilities | 115.94B | 122.17B | 123.53B | 126.60B | 126.69B | 129.65B |
| Stockholders Equity | 129.71B | 147.23B | 130.81B | 129.91B | 102.95B | 97.25B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | -1.46B | -7.66B | 3.83B | 2.53B | 3.26B |
| Operating Cash Flow | 0.00 | 3.41B | 5.00M | 10.49B | 6.15B | 8.77B |
| Investing Cash Flow | 0.00 | 2.12B | 15.10B | 1.92B | -1.62B | -5.86B |
| Financing Cash Flow | 0.00 | -9.66B | -9.23B | -8.45B | -5.93B | -6.57B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
69 Neutral | ¥602.46B | 8.32 | 5.02% | 2.12% | 9.83% | 130.42% | |
68 Neutral | ¥2.47T | 9.56 | 5.18% | 1.98% | 9.30% | 981.30% | |
61 Neutral | $10.43B | 7.12 | -0.05% | 2.87% | 2.86% | -36.73% | |
59 Neutral | ¥122.92B | 11.06 | 11.58% | 1.62% | 4.90% | -24.31% | |
59 Neutral | ¥173.21B | 13.92 | 6.77% | 2.30% | 6.58% | 63.12% | |
58 Neutral | ¥625.27B | 15.50 | 3.12% | 2.83% | -6.02% | 19.06% | |
51 Neutral | ¥13.99B | 7.31 | -111.61% | ― | -0.57% | ― |